Chemical stability of 2-arachidonylglycerol under biological conditions

Chemistry and Physics of Lipids

Volumn 119, Issue 1-2, 2002, Pages 69-82

  Rouzer, Carol A ^a   Ghebreselasie, Kebreab ^a   Marnett, Lawrence J ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Arachidonylglycerol; Cannabinoid; Eicosanoid; Endocannabinoid; Evaporative light scattering detection; Monoacyl glycerol

Indexed keywords

2 ARACHIDONOYLGLYCEROL; BUFFER; ESTER; LIGAND;

ARTICLE; BIOLOGY; CATALYSIS; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; EVAPORATION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INCUBATION TIME; IONIC STRENGTH; ISOLATION PROCEDURE; ISOMER; LIGHT SCATTERING; LIPID ANALYSIS; MIGRATION; OXIDATION; PRIORITY JOURNAL; TEMPERATURE; TIME;

ARACHIDONIC ACIDS; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA; DRUG STABILITY; GLYCERIDES; LIGANDS; OXIDATION-REDUCTION; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0036775411     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(02)00068-3     Document Type: Article

References (22)

1. Beltramo M., Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport. 11:2000;1231-1235.
2. Ben-Shabat S., Fride E., Sheskin T., Tamiri T., Rhee M.H., Vogel Z., Bisogno T., De Petrocellis L., Di Marzo V., Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 353:1998;23-31.
3. Berdyshev E.V., Schmid P.C., Krebsbach R.J., Schmid H.H.O. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J. 15:2001;2171-2178.
4. Bisogno T., Sepe N., Melck D., Maurelli S., De Petrocellis L., Di Marzo V. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J. 322:1997;671-677.
5. Bisogno T., Maccarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agrò A., Hillard C., Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 268:2001;1982-1989.
6. Di Marzo V. 2-Arachidonoyl-glycerol as an 'endocannabinoid': limelight for a formerly neglected metabolite. Biochemistry (Mosc). 63:1998;13-21.
7. Di Marzo V., Bisogno T., Sugiura T., Melck D., De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem. J. 331:1998;5-9.
8. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J.A., Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264:1999;258-267.
9. Fitzpatrick F.A., Wynalda M.A. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 258:1983;11713-11718.
10. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., Hipkin R.W. Endocannabinoid 2-arachidonylglycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57:2000;1045-1050.
11. Goparaju S.K., Ueda N., Taniguchi K., Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57:1999;417-423.
12. Jarrahian A., Manna S., Edgemond W.S., Campbell W.B., Hillard C.J. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J. Neurochem. 74:2000;2597-2606.
13. Kozak K.R., Rowlinson S.W., Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275:2000;33744-33749.
14. Martin J.B. The equilibrium between symmetrical and unsymmetrical monoglycerides and determination of total monoglycerides. J. Amer. Chem. Soc. 75:1953;5483-5485.
15. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Petwee R.G., Griffin G., Bayewitch M., Barg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:1995;83-90.
16. Moody J.S., Kozak K.R., Ji C., Marnett L.J. Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry. 40:2001;861-866.
17. Piomelli D., Beltramo M., Glasnapp S., Lin S.Y., Goutopoulos A., Makriyannis X.Q., Makriyannis A. Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. USA. 96:1999;5802-5807.
18. Schmid P.C., Schwartz K.D., Smith C.N., Krebsbach R.J., Berdyshev E.V., Schmid H.H.O. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. Chem. Phys. Lipids. 104:2000;185-191.
19. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
20. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Ito K., Yamashita A., Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215:1995;89-97.
21. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. J. Biol. Chem. 275:2000a;605-612.
22. Sugiura T., Waku K. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids. 108:2000b;89-106.